Trodelvy 180 MG vials
Ended Awarded
- Contract number
- SPE2DR26FQQ2E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,101
Award facts
- Contract value 100% obligated
- $10,100.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Trodelvy 180 mg vials, a specialty pharmaceutical product used in oncology treatment. This firm fixed price delivery order, valued at $10,100.70, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The delivery order is scheduled for completion by December 9, 2025, with performance based in Conshohocken, Pennsylvania, the company's corporate headquarters. No set-aside designation was applied to this award, indicating it was competitively awarded through standard federal procurement processes.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor within the Defense Logistics Agency's Medical Supply Chain, supplying a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare systems. Through its DLA Troop Support Medical prime vendor vehicle, the company fulfills pharmaceutical needs across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard. This delivery order for Trodelvy exemplifies the company's role in providing specialized oncology medications as part of the DLA's broader pharmaceutical support mission for federal healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FQQ2E?
SPE2DR26FQQ2E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FQQ2E worth?
The government has obligated $10,101 on SPE2DR26FQQ2E.
Is contract SPE2DR26FQQ2E an order under another contract?
Yes. SPE2DR26FQQ2E is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQQ2E competed?
The extent of competition for SPE2DR26FQQ2E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award